Strong 1Q 2026 Consolidated Results: Turnaround to Profit, Significant Revenue and OP Growth
-
Consolidated revenue in 1Q 2026: 32,567M KRW, +16.42% QoQ, +14.49% YoY
-
Operating profit: 6,345M KRW, +655.27% QoQ, +35.16% YoY
-
Pre-tax profit from continuing ops: 41,564M KRW, turnaround from loss (-201,233M in prior Q) and +589.69% YoY
-
Net profit: 41,299M KRW, turnaround from loss (-193,998M in prior Q) and +925.36% YoY
-
Controlling interest net profit: 41,299M KRW, turnaround
-
These are preliminary figures, subject to change after auditor review
KOSPI Filing Information
-
Filing: Consolidated Financial Statements Basis Operating (Provisional) Results (Fair Disclosure)
-
Company: BioNote (377740)
-
Submission: BioNote, Inc.
-
Receipt: 05-13-2026
-
Under KRX KOSPI Market Division